Clinical Trial Update: Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of metyrapone in patients with Mild Autonomous Cortisol Secretion and Autonomous Cortisol Secretion; the trial is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomous Cortisol Secretion

Drugs mentioned

• Metyrapone (Metyrapone)

Snippet

Sponsor: Mayo Clinic | Conditions: Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS) | Phase 2 | Status: NOT_YET_RECRUITING